Onsdag 5 November | 23:00:48 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-10-23 07:30 Kvartalsrapport 2026-Q3
2026-08-26 07:30 Kvartalsrapport 2026-Q2
2026-04-29 07:30 Kvartalsrapport 2026-Q1
2026-02-04 07:30 Bokslutskommuniké 2025
2025-10-28 - Extra Bolagsstämma 2025
2025-10-24 - Kvartalsrapport 2025-Q3
2025-08-22 - Kvartalsrapport 2025-Q2
2025-04-25 - Kvartalsrapport 2025-Q1
2025-04-09 - X-dag bonusutdelning SLEEP 1.15
2025-04-09 - X-dag ordinarie utdelning SLEEP 1.85 SEK
2025-04-08 - Årsstämma
2025-02-04 - Bokslutskommuniké 2024
2024-10-24 - Kvartalsrapport 2024-Q3
2024-07-26 - Kvartalsrapport 2024-Q2
2024-05-03 - Kvartalsrapport 2024-Q1
2024-04-12 - X-dag ordinarie utdelning SLEEP 1.30 SEK
2024-04-12 - X-dag bonusutdelning SLEEP 1
2024-04-11 - Årsstämma
2024-02-08 - Bokslutskommuniké 2023
2023-11-23 - Extra Bolagsstämma 2023
2023-10-25 - Kvartalsrapport 2023-Q3
2023-07-27 - Kvartalsrapport 2023-Q2
2023-05-09 - X-dag bonusutdelning SLEEP 6
2023-05-09 - X-dag ordinarie utdelning SLEEP 1.00 SEK
2023-05-08 - Årsstämma
2023-04-27 - Kvartalsrapport 2023-Q1
2023-02-10 - Bokslutskommuniké 2022
2022-10-28 - Kvartalsrapport 2022-Q3
2022-07-29 - Kvartalsrapport 2022-Q2
2022-05-11 - X-dag ordinarie utdelning SLEEP 0.00 SEK
2022-05-10 - Årsstämma
2022-04-27 - Kvartalsrapport 2022-Q1
2022-02-15 - Bokslutskommuniké 2021
2021-11-12 - Kvartalsrapport 2021-Q3
2021-08-13 - Kvartalsrapport 2021-Q2

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorInformationsteknik
IndustriProgramvara
Sleep Cycle är verksamt inom teknikbranschen och fokuserar på utveckling och distribution av en mobilapp för sökanalys och väckning. Bolagets produkter riktar sig till privatpersoner som vill förbättra sin sömnkvalitet och välbefinnande. Verksamheten är global med en huvudsaklig närvaro i Europa, Nordamerika och Asien. Sleep Cycle grundades 2001 och har sitt huvudkontor i Göteborg.
2025-10-27 10:15:00

Sleep Cycle, a leader in AI-based sleep analysis, announced today that the company is entering a pilot phase of a collaboration with Ultrahuman, a global player in the personal health and wellness space. The collaboration involves the licensing of Sleep Cycle’s “Sleep SDK” to enhance Ultrahuman’s self-quantification strategy, helping users log and analyze multiple biomarkers to gain a holistic view of the body and optimize health and performance.

The pilot phase aims to explore how Sleep Cycle’s technology can be integrated into Ultrahuman’s ecosystem to create additional value for users around the world. If successful, the goal is to establish an expanded, long-term partnership.

“We see Ultrahuman as an ideal partner for Sleep Cycle. They are a fast-growing company with a strong global presence and a high-quality ecosystem for personal health. Our technology can play an important role in strengthening their offering, and this aligns perfectly with our strategy to expand beyond our own consumer app and grow through partnerships and licensing – ‘Powered by Sleep Cycle’,” says Erik Jivmark, CEO of Sleep Cycle.

“At Ultrahuman, we are always on the lookout for the most advanced and reliable technologies to strengthen our offering and improve users’ wellbeing. Sleep Cycle has demonstrated a unique ability to combine science and usability, and we look forward to evaluating how their solutions can complement our platform,”says Mohit Kumar, founder of Ultrahuman.

Sleep Cycle’s strategy rests on two pillars: continued growth in its own consumer business, and an increasing share of revenue from licensing the company’s technology to partners in health, wellness, and medical technology. The collaboration with Ultrahuman marks an important step in this development and demonstrates the potential of the company’s technology to reach broader audiences and create new revenue streams.

“By making our world-leading sleep technology available to other players, we can create long-term value for users, partners, and shareholders alike. This collaboration is a clear example of how we are executing on that strategy,” says Elisabeth Hedman, CFO & Head of IR at Sleep Cycle.

For more information please contact: